早期乳腺癌保乳手术联合术中放射治疗的中期疗效观察

Mid-term effect of breast-conserving surgery combined with intraoperative radiotherapy on early breast cancer

  • 摘要: 目的 观察早期乳腺癌保乳手术联合术中放射治疗的中期临床疗效、安全性和美容效果。方法 回顾性分析解放军总医院第一医学中心2008年11月-2012年3月收治的63例早期乳腺癌患者,所有患者均行保乳手术联合术中放射治疗,术后随访评价患者不良反应、生存情况以及美容效果。结果 至2019年3月,本组中位随访时间102(80~120)个月,患者总生存率98.4%,无病生存率90.5%。7例(11.1%)患者出现Ⅰ级放射性肺损伤,10例(15.9%)出现手术部位局部硬化,5例(7.9%)出现皮肤颜色改变,16例(25.4%)出现手术部位疼痛。61例美容效果达到优(48例,78.7%)、良(13例,21.3%)水平。放射性肺损伤发生率和美容效果与术中放疗剂量关联不显著(P>0.05)。结论 早期乳腺癌保乳手术联合术中放射治疗可达到良好的疗效和美容效果,无严重不良反应。

     

    Abstract: Objective To observe the mid-term effect,safety and cosmetic effect of breast-conserving surgery combined with intraoperative radiotherapy (IORT) on early breast cancer. Methods Clinical data about 63 early breast cancer patients who underwent breast-conserving surgery combined with IORT in the First Medical Center of Chinese PLA General Hospital from November 2008 to March 2012 were retrospectively analyzed.The adverse reactions,outcomes and cosmetic effect were evaluated during follow-up.Results By March 2019,the median follow-up time was 102 months (range,80-120 months),with the overall survival rate of 98.4% (62/63) and the disease-free survival rate of 90.5% (57/63).In terms of adverse events,7 patients (11.1%,7/63) developed grade I radiation-induced pulmonary injury,and 10 patients (15.9%,10/63) had radiation fibrosis in the surgical site,5 patients (7.9%,5/63) had skin color changes,16 patients (25.4%,16/63) had surgical site pain.In terms of cosmetic effects,excellent cosmetic effect was achieved in 48 cases (78.7%) and good effect in 13 cases (21.3%).There was no significant correlation between the incidence of radiation-induced lung injury,cosmetic effects,and intraoperative radiotherapy dose (P>0.05). Conclusion The curative effect and cosmetic effect of breast-conserving surgery combined with intraoperative radiotherapy for early breast cancer are good,without any serious adverse reactions.

     

/

返回文章
返回